Impact of biochemical failure on long-term clinical outcome after radical prostatectomy for prostate cancer in Japan

Prostate Cancer and Prostatic Diseases

Volumn 7, Issue 2, 2004, Pages 152-157

  Egawa, S ^a   Matsui, Y ^b   Matsumoto, K ^a   Suyama, K ^a   Arai, Y ^b   Kuwao, S ^a   Baba, S ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

Biochemical failure; Overall survival; Prostate specific antigen; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; JAPAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SEMINAL VESICLE DISEASE; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DISEASE PROGRESSION; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 3142753526     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500715     Document Type: Article

References (19)

1. Pound CR et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999; 281: 1591-1597.
2. Jhaveri FM, Zippe CD, Klein EA, Kupelian PA. Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results. Urology 1999; 54: 884-890.
3. Kupelian PA et al. Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era. Int J Radial Oncol Biol Phys 2002; 52: 704-711.
4. D'Amico AV et al. Pretreatment predictors of time to cancer specific death after prostate specific antigen failure. J Urol 2003; 169: 1320-1324.
5. Machida T et al. Clinical evaluation of a new kit (IMx PA Dainapack) for detection of serum prostate specific antigen. Acta Urol Japon 1993; 39: 977-984.
6. International Union against Cancer. TNM Atlas, 3rd edn., 2nd revision. Springer: New York 1992; pp 241-250.
7. UICC International Union. In: Sobin LH, Wittekind CH (eds). UICC International Union Against Cancer, TNM classification of malignant tumors. 6th edn. John Wiley & Sons, Inc: New York 2002; pp 184-187.
8. Egawa S et al. Infrequent involvement of the anterior base in low-risk patients with clinically localized prostate cancer and its possible significance in definitive radiation therapy. Jpn J Clin Oncol 2000; 30: 126-130.
9. Japanese Urological Association. General Rule for Clinical and Pathological Studies on Prostatic Cancer, 3rd edn. Japan: The Japanese Pathological Society 2001.
10. National Institute of Population and Social Security Research: Population Projections for Japan: 2001-2050 (with long-range population projects: 2051-2100).
11. Egawa S. Detection of prostate cancer by prostate-specific antigen. Biomed Pharmacother 2001; 55: 130-134.
12. Egawa S et al. Impact of life expectancy and tumor doubling time on the clinical significance of prostate cancer in Japan. Jpn J Clin Oncol 1997; 27: 394-400.
13. Partin AW, Oesterling JE. The clinical usefulness of prostate specific antigen: update 1994. J Urol 1994; 15: 1358-1368.
14. Zincke H et al. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 1994; 152: 1850-1857.
15. Catalona WJ, Smith DS. Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. J Urol 1998; 160: 2428-2434.
16. Gerber GS et al. Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA 1996; 276: 615-619.
17. Hull GW et al. Cancer control with radical prostatectomy alone in 1000 consecutive patients. J Urol 2002; 167: 528-534.
18. Egawa S et al. Observations of prostate specific antigen doubling time in Japanese patients with nonmetastatic prostate carcinoma. Cancer 1999; 86: 463-469.
19. Bianco Jr FJ et al. Radical prostatectomy nomograms in black American men: accuracy and applicability. J Urol 2003; 170: 73-77.